Reshape Lifesciences Inc (RSLS) - News Archive

Showing 9 of 9 results.

ReShape Lifesciences: Strategic Reverse Split & AI Alliance Set to Pave New Path Amid Economic Tides,

In a pivotal move aimed at stabilizing its financial position and enhancing shareholder value, ReShape Lifesciences recently announced a 1-for-25 reverse stock split effective at the commencement of trading on May 9, 20...

May 7, 2025 • Major Pharmaceutical Preparations Industry Stock Market Announcement

AI-Powered Recovery ReShape Lifesciences and Motion Informatics Forge Alliance to Transform U.S. Neurorehab...

ReShape Lifesciences has announced a groundbreaking partnership with Motion Informatics, positioning itself at the forefront of neurorehabilitation by entering into an exclusive U.S. distribution agreement. This collabo...

Apr 10, 2025 • Major Pharmaceutical Preparations Industry Contract

ReShape Lifesciences Sets the Stage for Growth with Vyome Therapeutics Merger and Biorad Medisys Acquisition Amidst Groundbreaking Health Canada Approval,

Transactions Continue to Progress and Remain on Track Following ReShape Lifesciences Innovative Approaches in Weight Loss and Diabetes Management with New Health Canada Approval and Strategic Research CollaborationsIn a...

Jan 13, 2025 • Major Pharmaceutical Preparations Industry Merger and Acquisition

ReShape Lifesciences Pioneers Innovative Approaches in Weight Loss and Diabetes Management with New Health Canada Approval and Strategic Research Collaborations

In a remarkable leap forward for obesity management and diabetes treatment, ReShape Lifesciences has recently garnered Health Canada’s approval for its next-generation Lap-Band 2.0, equipped with the innovative FLEX Tec...

Nov 12, 2024 • Medical Equipment & Supplies Industry Management Announcement

Collaborating for a Cure ReShape Lifesciences and USC’s CARSS Innovate Next-Gen Diabetes Treatment,

Unveiling the Future of Diabetes Management: ReShape Lifesciences and USC s CARSS Invest in Groundbreaking Neuromodulation Technology In an exciting development for the diabetes treatment landscape, ReShape Lifesciences...

Nov 11, 2024 • Medical Equipment & Supplies Industry Product Service News S September Commencement Commerzbank Currently

ReShape Lifesciences and Vyome Therapeutics Merger Set to Transform Shareholder Landscape Amidst Promising Market Movements

In a significant development for investors and stakeholders, ReShape Lifesciences Inc. has announced that its merger with Vyome Therapeutics will officially take effect at the commencement of trading on September 23, 20...

Sep 19, 2024 • Medical Equipment & Supplies Industry Shares

ReShape Lifesciences and Vyome Therapeutics Announce Merger Agreement to Advance Treatment for Immuno-Inflammat...

In an exciting development within the pharmaceutical industry, ReShape Lifesciences has announced the signing of a definitive merger agreement with Vyome Therapeutics, a clinical stage specialty pharmaceutical company f...

Jul 9, 2024 • Medical Equipment & Supplies Industry Contract

Reshape Lifesciences: A Promising Rebirth towards Profitability in the Healthcare Market

Reshape Lifesciences: A Promising Turnaround in the MakingIn a recent announcement, Reshape Lifesciences provided an update on its 2024 cost reduction plan and reorganization strategy, signaling a significant shift towa...

Mar 4, 2024 • Medical Equipment & Supplies Industry Management Announcement

ReShape Lifesciences Collaborates with Maxim Group LLC to Explore Lucrative M&A Opportunities

In a groundbreaking move, ReShape Lifesciences Inc. (Nasdaq: RSLS), the leading physician-led weight loss and metabolic health-solutions company, has engaged Maxim Group LLC as its exclusive financial advisor. This stra...

Dec 20, 2023 • Medical Equipment & Supplies Industry Merger and Acquisition